The Role of HbA1c Levels in DM Patients with Coronary Heart Disease Incidents

Putri Aulia Cahyani; Akina Maulidhany Tahir; Rezky Putri Indarwati Abdullah; Irna Diyana Kartika Kamaluddin; Abdul Mubdi Ardiansar Arifuddin Karim

doi:10.37899/journallamedihealtico.v7i4.5924

Putri Aulia Cahyani Professional Medicine Study Program, Faculty Of Medicine, Universitas Muslim Indonesia
Akina Maulidhany Tahir Faculty f Medicine, Universitas Muslim Indonesia
Rezky Putri Indarwati Abdullah Faculty f Medicine, Universitas Muslim Indonesia
Irna Diyana Kartika Kamaluddin Faculty f Medicine, Universitas Muslim Indonesia
Abdul Mubdi Ardiansar Arifuddin Karim Faculty f Medicine, Universitas Muslim Indonesia

DOI: https://doi.org/10.37899/journallamedihealtico.v7i4.5924

Keywords: Coronary Heart Disease, Diabetes Mellitus, Glycemic Control, Hba1c, Cardiovascular Complications Atherosclerosi

Abstract

Diabetes mellitus is a major risk factor for coronary heart disease (CHD), particularly when long-term glycemic control is inadequate. Glycated hemoglobin (HbA1c) reflects average blood glucose levels over the previous two to three months and may serve as an indicator of cardiovascular risk. This study aimed to examine the role of HbA1c levels in the incidence, severity, and clinical outcomes of CHD among patients with diabetes mellitus. A narrative literature review was conducted using articles published between 2021 and 2026 and retrieved from Google Scholar, PubMed, ScienceDirect, and ResearchGate. Studies were selected according to predetermined inclusion and exclusion criteria and critically evaluated using the Joanna Briggs Institute appraisal instruments. A total of 29 relevant studies were reviewed and synthesized narratively. Most studies demonstrated that elevated HbA1c levels were associated with an increased risk of CHD, greater coronary artery stenosis, more severe atherosclerotic lesions, and poorer cardiovascular outcomes, including major adverse cardiovascular events, restenosis following percutaneous coronary intervention, hospital readmission, and mortality. However, several cross-sectional studies reported no statistically significant association, possibly because of differences in sample characteristics, study design, duration of diabetes, assessment methods, and accompanying cardiovascular risk factors. Overall, poor glycemic control contributes to the development and progression of CHD through chronic hyperglycemia, oxidative stress, endothelial dysfunction, inflammation, and accelerated atherosclerosis. Regular HbA1c monitoring and individualized glycemic control are therefore important components of cardiovascular risk prevention and diabetes management.

References

Adninta, L., Samsuria, I., & Limijadi, E. K. S. (2022). Correlation between HbA1c and triglyceride level with coronary stenosis degree in type 2 diabetes mellitus with coronary heart disease. Open Access Macedonian Journal of Medical Sciences, 10(B), 1463–1468. https://doi.org/10.3889/oamjms.2022.8859

Alfreyzal, M., Paizer, D., Anggraini, D., Syahfitri, R. D., & Azhari, M. H. (2024). Edukasi kesehatan pada keluarga DM dengan masalah keperawatan pemeliharaan kesehatan tidak efektif. Jurnal Kesehatan, 13(1).

Amirudin, I., & Yunitasari, E. (2021). Diabetes distress dan risiko penyakit kardiovaskular pada penderita DM tipe II. Jurnal Aisyah: Jurnal Ilmu Kesehatan, 6(Suppl. 1), 187–191. https://dx.doi.org/10.30604/jika.v6iS1.784

Ardini, F., & Halim, S. (2023). Hubungan HbA1c dengan komplikasi makrovaskular pada diabetes melitus tipe 2 di RS Hermina Kemayoran. Jurnal Kedokteran Meditek, 29(3), 1–8. https://doi.org/10.31004/jkt.v4i4.22366

Astutisari, I. D., Darmini, A. Y., & Wulandari, I. A. (2021). Hubungan pola makan dan aktivitas fisik dengan kadar gula darah pada pasien DM tipe 2 di Puskesmas Manggis I. Jurnal Riset Kesehatan Nasional, 6(2). https://doi.org/10.37294/jrkn.v6i2.350

Baniu, A. S., Sauriasari, R., & Riyadina, W. (2022). Treatment adherence and incidence of coronary heart disease in type 2 diabetes mellitus patients. Journal of Multidisciplinary Healthcare, 15, 1789–1798.

Butalia, S., Chu, L. M., Dover, D. C., Lau, D., Yeung, R. O., Eurich, D. T., ... & Kaul, P. (2024). Association between hemoglobin A1c and development of cardiovascular disease in Canadian men and women without diabetes at baseline: a population‐based study of 608 474 adults. Journal of the American Heart Association, 13(9), e031095. https://doi.org/10.1161/jaha.123.031095

Carew, A. S., Warren, R. A., Bancks, M. P., Espeland, M. A., Bahnson, J. L., Lewis, C. L., ... & Cahill, L. E. (2024). The relationship between repeated measurements of HbA1c and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) study. Cardiovascular Diabetology, 23(1), 356. https://doi.org/10.1186/s12933-024-02448-z

Chen, J., Yin, D., & Dou, K. (2023). Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions. Cardiovascular Diabetology, 22(1), 146. https://doi.org/10.1186/s12933-023-01875-8

Dali, I. B., Ztati, M., Ait Yahya, A., El Jamily, M., & El Hattaoui, M. (2025). The Association of HbA1c with Severity of Coronary Artery Disease in Patients Presenting as Acute Coronary Syndrome. Cardiology and Angiology: An International Journal, 14(3), 45-51. https://doi.org/10.9734/ca/2025/v14i3498

Dykun, I., Kappo, N., Kampf, J., Babinets, O., Jánosi, R. A., Totzeck, M., ... & Mahabadi, A. A. (2025). Association of hemoglobin A1c levels with all-cause mortality in patients with coronary artery disease: the Essen Coronary Artery Disease registry. JACC: Advances, 4(3), 101624. https://doi.org/10.1016/j.jacadv.2025.101624

Ghaffari, S., Niafar, F., Separham, A., et al. (2025). Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of ST-elevation myocardial infarction in nondiabetic patients. BMC Cardiovascular Disorders, 25(1), 148. https://doi.org/10.1177/1753944715585500

Irawan, Q. P., Utami, K. D., Reski, S., et al. (2022). Hubungan indeks massa tubuh (IMT) dengan kadar HbA1c pada penderita DM tipe II di Rumah Sakit Abdoel Wahab Sjahranie. Formosa Journal of Science and Technology, 1(5). https://doi.org/10.55927/fjst.v1i5.1220

Jiao, X., Zhang, Q., Peng, P., & Shen, Y. (2023). HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease. Cardiovascular Diabetology, 22(1), 127. https://doi.org/10.1186/s13098-023-01015-y

Jyotsna, F. N. U., Ahmed, A., Kumar, K., Kaur, P., Chaudhary, M. H., Kumar, S., ... & Kakadiya, K. A. (2023). Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus, 15(8). https://doi.org/10.7759/cureus.43882

Kanna, D. N., & Eliyas, M. M. (2023). Arrhythmia heart syndrome-a silent killer. Current Research in Life Sciences, 15.

Klein, K. R., & Buse, J. B. (2020). The trials and tribulations of determining HbA1c targets for diabetes mellitus. Nature Reviews Endocrinology, 16(12), 717-730. https://doi.org/10.1038/s41574-020-00425-6

Kurniawan, D., Saelan, & Fitriana, R. N. (2025). Hubungan antara kadar HbA1c dan kolesterol total dengan keparahan penyakit jantung koroner di RSUD Dr. Moewardi. Avicenna Journal of Health Research, 8(1), 31–38. https://doi.org/10.53599/jip.v7i2.389

Lu, Y., Wang, W., Liu, J., Xie, M., Liu, Q., & Li, S. (2023). Vascular complications of diabetes: A narrative review. Medicine, 102(40), e35285. https://doi.org/10.1097/MD.0000000000035285

Matsushita, K., Ballew, S. H., Wang, A. Y. M., Kalyesubula, R., Schaeffner, E., & Agarwal, R. (2022). Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nature Reviews Nephrology, 18(11), 696-707. https://doi.org/10.1038/s41581-022-00616-6

Mhlaba, L., Mpanya, D., & Tsabedze, N. (2023). HbA1c control in type 2 diabetes mellitus patients with coronary artery disease: A retrospective study in a tertiary hospital in South Africa. Cardiovascular Journal of Africa, 34(6), 321–327. https://doi.org/10.3389/fcdhc.2023.1258792

Mijwil, M. M., Shukur, B. S., & Mahmood, E. S. (2022). The most common heart diseases and their influence on human life: A Mini-review. Journal of Advances in Medicine and Medical Research, 34(15), 26-36. https://doi.org/10.9734/JAMMR/2022/v34i1531396

Millisani, H. I., Prasetya, I., & Rohman, M. S. (2024). Correlation between HbA1c levels and intrastent restenosis incidence in patients with diabetes mellitus after percutaneous coronary intervention. Journal of Basic and Clinical Physiology and Pharmacology, 35(3), 1–8. https://doi.org/10.21776/ub.hsj.2024.005.04.10

Muhajiriansyah, & Binuko, R. S. D. (2023). Hubungan antara kadar HbA1c dan gula darah sewaktu (GDS) dengan kejadian hipertensi pada pasien DM tipe II di Rumah Sakit Darmayu Ponorogo. Health Information: Jurnal Penelitian, 15(2).

Nugroho, H., Ernawilis, Suheti, & Syamlan, S. F. (2023). Penyuluhan kesehatan tentang pengetahuan pencegahan DM di Desa Rawat Rengas. Jurnal Peduli Masyarakat, 5(4). https://doi.org/10.37287/jpm.v5i4.2358

Pálsson, R., & Patel, U. D. (2014). Cardiovascular complications of diabetic kidney disease. Advances in chronic kidney disease, 21(3), 273-280. https://doi.org/10.1053/j.ackd.2014.03.003

Patiung, G. M., Panda, A. L., & Rotty, M. P. F. (2025). Hubungan kadar HbA1c dengan keparahan penyakit arteri koroner berdasarkan pola angiografi pada pasien sindrom koroner akut di RS Prof. Dr. R.D. Kandou. e-CliniC, 13(1), 1–8. https://doi.org/10.59188/jcs.v4i12.3828

Pranowo, C. E., Rahimah, S. B., & Widiyastuti, E. (2025). Hubungan HbA1c dengan jenis penyakit kardiovaskular pada diabetes melitus tipe 2. Jurnal Kedokteran Komunitas, 13(1), 66–73. https://doi.org/10.29313/bcsms.v6i1.22234

Ramatillah, D. L., Aurelia, A., Panjaitan, E. N., Lubis, V. P. T., Rahman, I., Puspitasari, I. J., & Mahayanti, D. K. (2023). EDUKASI MENGENAI PENYAKIT JANTUNG KORONER KEPADA PASIEN DI PUSKESMAS KELURAHAN SUNTER AGUNG I. BERDIKARI, 6(1). https://doi.org/10.52447/berdikari.v6i1.6808

Rashid, A., Saeed, M. S., Ghouse, M. A., Kunju, A. K., Umar, N., Asif, A. E., ... & Shoaib, A. (2025). Association between glycated hemoglobin and severity of coronary artery disease in type 2 diabetic patients with myocardial infarction. Cureus, 17(3). https://doi.org/10.7759/cureus.81521

Ratulangi, S. E., & Sutanto, H. (2024). Pengaruh kendali glikemik pasien diabetes tipe 2 terhadap komplikasi penyakit jantung koroner. Jurnal Ilmiah Kesehatan Sandi Husada, 13(1), 45–52. https://doi.org/10.24912/tmj.v6i2.33362

Rimbayani, A. P. R., Rizqiea, N. S., & Suryandari, D. (2025). Nilai HbA1c dan keparahan penyakit jantung koroner. Jurnal Kedokteran Diponegoro, 14(2), 95–102.

Romera, I. C., Redondo-Antón, J., Rubio-de Santos, M., Díaz-Cerezo, S., Artime, E., Rafels-Ybern, A., ... & Conget, I. (2025). The association between HbA1c levels and the risk of myocardial infarction and stroke in people with type 2 diabetes: A post hoc analysis of the REPRESENT study. Diabetes Therapy, 16(6), 1229-1239. https://doi.org/10.1007/s13300-025-01727-6

Shanmuganathan, G., Anandhi, D., Subban, V., Kumaran, S., Mullasari, A. S., Philip, D. C., ... & Vijaianand, S. (2025). The influence of HbA1c levels on clinical outcomes in diabetic patients following percutaneous coronary intervention. Journal of Indian College of Cardiology, 15(4), 137-142. https://doi.org/10.4103/jicc.jicc_64_24

Simanjuntak, D. R., & Nugroho, R. A. (2025). Faktor risiko diabetes melitus dan prevalensi penyakit jantung koroner di RSU UKI tahun 2021–2023. Jurnal Kesehatan Masyarakat Indonesia, 20(1), 57–65. https://doi.org/10.33541/pro-life.v12i1.6660

Souisa, N. F., Santosa, B., & Limijadi, E. K. S. (2024). Correlation of HbA1c, triglyceride, HDL with the degree of stenosis in coronary heart patients with type 2 diabetes mellitus. Open Access Macedonian Journal of Medical Sciences, 12(B), 450–456. https://doi.org/10.31689/rmm.2024.31.2.117

Wei, W., Liang, Y., Guo, D., Xu, X., Xu, Q., Li, S., ... & Chen, S. (2022). Hyperglycemia newly detected by glycated hemoglobin affects all-cause mortality in coronary artery disease patients: a retrospective cohort study. Diabetes Research and Clinical Practice, 191, 110053. https://doi.org/10.1016/j.diabres.2022.110053

Wei, Y., Li, W., Luan, H., Tuerhongjiang, G., Yuan, Z., & Wu, Y. (2023). The association of glycated hemoglobin A1c with coronary artery disease, myocardial infarction, and severity of coronary lesions. Frontiers in Endocrinology, 14, 1198936. https://doi.org/10.1177/10815589221140593

Yu, M. G., Gordin, D., Fu, J., Park, K., Li, Q., & King, G. L. (2024). Protective factors and the pathogenesis of complications in diabetes. Endocrine reviews, 45(2), 227-252. https://doi.org/10.1210/endrev/bnad030